Skip to content

Clinical profile of hepatoblastoma.

Clinical Profile of Hepatoblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220418005
Enrollment
20
Registered
2022-04-18
Start date
2022-04-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatoblastoma hepatoblastoma, surgery, outcome

Interventions

Patients with hepatoblastoma(histopathological diagnosis)
Treatment
Patients with hepatoblastoma

Sponsors

Department of Surgical Gastroenterology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Months to 60 Months

Inclusion criteria

Inclusion criteria: patients who were diagnosed with hepatoblastoma

Exclusion criteria

Exclusion criteria: Other pathological causes of liver mass in children.

Design outcomes

Primary

MeasureTime frame
Mortality 5 years Not Statistical Method

Secondary

MeasureTime frame
Relapse of disease 5 years Not Statistical Method

Countries

India

Contacts

Public ContactSukanta Ray

Institute of Postgraduate Medical Educat

drsukantaray@yahoo.co.in08095960200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026